Emyria
Emyria operates a network of specialist medical clinics focused on collecting and commercializing clinical data. The company leverages proprietary software to gather anonymized patient data, which is then used to generate clinical evidence. This positions Emyria uniquely in the healthcare sector, combining medical services with data-driven insights.
Short position
Emyria (ASX:EMD) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6,369 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.10% in February 2020. EMD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4EMD community
Research Threads
Bull, bear, catalyst, and news-reaction posts tied directly to EMD.
Start the first EMD research thread
Anchor the conversation with a thesis, a catalyst, or a question worth debating.